The Effect of Intraoral Transcutaneous Electrical Nerve Stimulation in Orthodontics Pain
Launched by UNIVERSITY OF THE PACIFIC · Aug 22, 2024
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at whether a special device called an intraoral Transcutaneous Electrical Nerve Stimulation (TENS) can help reduce pain for people getting braces or other orthodontic treatments. The TENS device sends gentle electrical signals to the nerves in one side of the mouth to see if it can lessen the discomfort that often comes with orthodontic adjustments. In this study, participants will have the TENS device applied to one side of their mouth while the other side will receive a non-working (placebo) device. Researchers will check in on how much pain the participants feel at different times after their braces are put on.
To join this study, participants should be generally healthy and undergoing orthodontic treatment that involves full braces. They should not be taking any pain medications during the study. In total, the trial will include up to 150 participants, and it aims to find out if the TENS device can make orthodontic procedures more comfortable. This information could help improve patient care and ease the discomfort of getting braces.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • General Health: Patients who are generally healthy.
- • Orthodontic Treatment: Patients undergoing orthodontic treatment that requires the use of full-fixed appliances.
- • No Pain Medication: Patients not currently taking any medications for pain management.
- Exclusion Criteria:
- • Patients with a history of seizures
- • Patients with or with a history of cardiac arrhythmias or pacemaker treatment
- • Patients taking any over-the-counter or prescription pain medication during the testing period.
About University Of The Pacific
The University of the Pacific is a distinguished higher education institution known for its commitment to research and innovation in various fields, including healthcare. As a clinical trial sponsor, the university leverages its extensive academic resources and expertise to advance medical knowledge and improve patient outcomes. The institution fosters collaboration among interdisciplinary teams, utilizing state-of-the-art facilities and a robust network of clinical partners to conduct rigorous, ethical research. With a focus on translating findings into practical applications, the University of the Pacific is dedicated to contributing to the advancement of medical science and the enhancement of community health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
San Francisco, California, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported